Mice receiving SH3gl1 deficient thymocytes developed nearly no arthritis (Fig. 3c) and had fewer antigen-specific cells compared to the wild-type recipients as determined by an in vitro recall assay using the GPI peptide while no significant difference could be seen in mitogen activated cells (Fig. 3d). Here, SH3GL1 is linked to arthritic joint disease.